Interestingly, we did not observe growth inhibitory activity with DEX in NSCLC-neuroendocrine (NSCLC-NE) lines, and SCLC lines where GR has been postulated to be a tumor suppressor (27). The gene discussed is NR3C1; the disease is neoplasm.